An ultra‐fast MRI protocol in dementia enabled by Wave‐CAIPI
Miguel A Rosa Grilo, Haroon R Chughtai, David L Thomas, David M Cash, Millie Beament, William Coath, Lloyd Prosser, Ian B Malone, Emma Lim, H Rolf Jäger, Daniel C Alexander, Nick C Fox, Catherine J Mummery, Geoff JM Parker, Frederik Barkhof- Psychiatry and Mental health
- Cellular and Molecular Neuroscience
- Geriatrics and Gerontology
- Neurology (clinical)
- Developmental Neuroscience
- Health Policy
- Epidemiology
Abstract
Background
Structural brain imaging is essential for the diagnostic workup in dementia and for safety monitoring of disease modifying therapies. MRI has several advantages over other imaging techniques, but its use is limited by cost and availability. Reducing acquisition time holds the potential for its democratisation. We developed a prototype ultra‐fast MRI protocol based on an optimised 3D parallel imaging approach. Here we present the finalised version, developed using a qualitative and quantitative approach to optimisation.
Method
In this ongoing real‐world study, participants are sequentially recruited from the cognitive disorders' clinics of a tertiary centre. Patients due to have a standard 3T MRI scan as part of their diagnostic pathway are eligible. The standard‐of‐care protocol includes T1w, T2w, FLAIR and T2*/SWI sequences [scan time ∼18mins]. The prototype rapid protocol utilises Siemens work‐in‐progress 3D Wave‐CAIPI (Controlled Aliasing in Parallel Imaging) sequences, enabling a reduction in scan time of more than 60% (table 1). For qualitative analysis, scans (of 9 individuals) were reviewed by six raters and assessed side‐by‐side against the gold‐standard scan for diagnostic utility. For a quantitative analysis, volumes were calculated from T1w scans using the default cortical reconstruction and volumetric segmentation pipeline in FreeSurfer 7.3.2. Key volumes (e.g., deep grey matter, cortical grey matter, white matter) for each participant were compared between the two protocols. Independent visual QC was performed on T1w datasets by an experienced clinical trials team.
Result
Side‐by‐side visual assessment results of 9 participants is shown in figure 1. For all sequences bar FLAIR, raters scored the ultra‐fast sequences of comparable image quality in at least 67% of cases. For quantitative analysis, 10 T1w sequence pairs were reviewed, with 1 clinical scan failing QC due to motion. Bland‐Altman analyses (figure 2.) comparing volumes between the clinical and ultra‐fast sequences show little bias.
Conclusion
Our preliminary results demonstrate that for most contrasts the ultra‐fast sequences are diagnostically non‐inferior and quantitatively equivalent to the clinical protocol both for diagnosis and for safety monitoring.